Amy Sommers

Amy Sommers

K&L Gates LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

China’s (Shanghai) Pilot Free Trade Zone: Widening the Outbound Investment Pipeline

The launch of the China (Shanghai) Pilot Free Trade Zone (FTZ) last September attracted a lot of attention both inside and outside of China. Since then, the lack of progress implementing stated goals for the FTZ as a...more

7/23/2014 - China Foreign Investment Free Trade Agreement Free Trade Zone

When Family Comes First

Ningbo native Lisa Sun spent two decades at several multi-nationals in China, climbing the ranks in the human resources sector. Three years ago, however, she was forced to make a tough call. Her son, who was in primary school...more

3/10/2014 - China Human Resources Professionals Multinationals Women in the Law

China’s New Consumer Protection Law: Dramatic Changes Ahead

On October 25, 2013, China’s President and Chairman of the Communist Party of China Xi Jinping signed off on the long-expected revised Law on the Protection of Consumer Rights and Interests (the “New Consumer Law”), which is...more

12/23/2013 - China Data Protection Financial Regulatory Reform Personally Identifiable Information Standard of Care

An Untapped Market: China’s Aging Population and the Senior Housing Opportunity

Until recently, the notion of a senior housing market in China was nothing more than fantasy. Tradition held that elder care was primarily the province of the family, as children were responsible for supporting and assisting...more

9/17/2013 - China Elder Care Elder Issues

Tied to Your Desk? Blocked at the Door? Changes in China’s Visa Policies for Foreigners

Expatriates and foreign investors beware! China’s new immigration law and policies have changed the visa requirements for foreigners who would like to work in the PRC and adopted heightened penalties for those who violate the...more

7/31/2013 - China Foreign Corporations Foreign Investment Foreign Workers Visas

“Can You Sleep Well at Night?”: Multinational Executives Detained in China Due to Bribery Concerns

Any company doing business in China has to wonder whether they might find themselves in the unwelcome spotlight recently turned on certain participants in China’s pharmaceutical market....more

7/22/2013 - Bribery C-Suite Executives China Corruption Detainees Enforcement Actions GlaxoSmithKline Multinationals Pharmaceutical White Collar Crimes

Anti-Corruption: Effective Compliance Begins with the Assessment of Risks

Virtually every authoritative source of guidance on effective anti-corruption compliance emphasizes the importance of conducting a company-wide “risk assessment.” For example, U.S. authorities have stressed with regard to the...more

4/11/2013 - Anti-Corruption Compliance FCPA Risk Assessment UK Bribery Act

7 Results
|
View per page
Page: of 1